（文章来源：证券日报） 证券日报网讯 12月12日，盈康生命在互动平台回答投资者提问时表示，截至2025年12月10日，公司股 东总数为20115户。 ...

Core Insights - The China Securities Association released the results of the "2025 Evaluation of Board Secretaries of Listed Companies," with 282 board secretaries receiving a 5A rating, 589 receiving a 4A rating, and 687 receiving a 3A rating [1] - The evaluation criteria included ten major standards and 67 indicators, covering areas such as compliance, information disclosure, internal control, investor relations management, and social responsibility [1] - Board secretaries play a crucial role in corporate governance, acting as gatekeepers for compliance and as a bridge between the capital market, investors, and company management [1] Group 1 - A total of 282 board secretaries achieved the highest 5A rating, reflecting their exceptional performance and the governance standards of their respective companies [1] - The evaluation emphasizes the importance of board secretaries in maintaining corporate transparency and sustainable development [1] - The recognition of board secretaries is not only a personal accolade but also highlights the benchmark status of their companies in governance and transparency [1] Group 2 - Notable companies with 5A rated board secretaries include COSCO Shipping Energy, Fosun Pharma, and Kweichow Moutai, among others [2] - The list of 5A rated board secretaries includes individuals such as Ni Yidan from COSCO Shipping Energy and Dong Xiaoxian from Fosun Pharma [2] - The evaluation results serve as a reference for best practices in corporate governance and investor relations within the industry [1][2]

（编辑 王雪儿） 证券日报网讯 12月5日，盈康生命在互动平台回答投资者提问时表示，公司始终高度重视市值管理，并 坚持在聚焦主业、提升经营效率和盈利能力的基础上，综合运用包括增持回购、股权激励、非公开发行 股票、并购等方式系统性地强化市值管理与投资者回报。2025年，公司审议通过了旨在完善治理与回报 机制的相关制度。外延发展方面，公司于2025年上半年完成对长沙珂信肿瘤医院51%股权的收购，旨在 进一步夯实在医疗服务领域的肿瘤特色，增厚业绩并增强持续经营能力。此外，公司始终致力于提升规 范运作与信息披露质量，以有效传递公司价值。 ...

Group 1 - The high-pressure oxygen chamber concept increased by 0.92%, ranking second among concept sectors, with eight stocks rising, including Hangzhou Oxygen, Dahu Co., and Jinling Pharmaceutical, which rose by 5.56%, 1.13%, and 1.09% respectively [1] - The leading stocks in terms of net inflow of main funds in the high-pressure oxygen chamber sector include Samsung Medical, with a net inflow of 4.9759 million yuan, followed by Aoyang Health, Yingkang Life, and Weiao Co. [2][3] - The net inflow ratios for Yingkang Life, Weiao Co., and Aoyang Health were 2.53%, 1.60%, and 1.49% respectively, indicating strong interest from main funds [3] Group 2 - The high-pressure oxygen chamber sector experienced a net outflow of 45 million yuan today, despite some stocks seeing net inflows [2] - Stocks with significant declines include Beiyikang, China Railway Construction, and Yingkang Life, which fell by 0.40%, 0.20%, and 0.20% respectively [1] - The trading volume and turnover rates for stocks like Hangzhou Oxygen and International Medical showed negative net inflows, indicating potential selling pressure [4]

Core Viewpoint - Yingkang Life is actively advancing the second phase of construction for Changsha Kexin Tumor Hospital, aiming to enhance its medical service capacity significantly [1] Group 1: Hospital Development - The hospital is expected to add over 400 new beds as part of its expansion efforts [1] - Major medical equipment updates and campus renovations have been completed, optimizing bed resources [1] - The goal is to establish the hospital as a leading tumor specialty hospital in Central China [1]

Group 1: Hospital Overview - Changsha Kexin Tumor Hospital officially opened in September 2015, approved by the Hunan Health Commission, and is a tertiary specialized cancer hospital [1][2] - The hospital occupies an area of 27 acres with an initial capacity of 420 beds, currently operating at full capacity, and employs over 500 staff [2] - It has been recognized with multiple awards, including "Excellent Department in Improving Medical Services" and "Top 100 Service Enterprises in Xiangjiang New Area" [2] Group 2: Differentiation and Service Model - The hospital focuses on a patient-centered service system, implementing a "Ten Fears and Ten Promises" service commitment mechanism to enhance patient experience [3] - The "Medical Square" service model integrates various professional resources to provide comprehensive, one-stop services, contributing to a sustainable brand reputation [3] Group 3: Technological and Equipment Advantages - In the first nine months of 2025, the hospital performed over 7,000 minimally invasive surgeries, with an 8% year-on-year increase [4] - The introduction of advanced DSA equipment increased monthly surgical volume from 465.5 to 788.4, a growth rate of 69% [5] - New radiation therapy equipment, such as TOMO-C, is expected to enhance precision treatment capabilities [5] Group 4: Future Development Plans - The hospital is preparing for a second phase of construction, aiming to add over 400 beds to expand medical service capacity [6] - The goal is to establish Changsha Kexin as a leading tumor specialized hospital in Central China, enhancing service capabilities and brand position [6] Group 5: Long-term Strategic Planning - The company embraces healthcare reform, aiming to provide timely detection, precise treatment, and rapid recovery through differentiated medical solutions [7] - The resource allocation strategy follows a "3/3/3" model, focusing on social healthcare, personalized services, and continuous health management for outpatients [8] - The company is transitioning from a traditional medical group to a health management technology company, leveraging AI to improve service efficiency and quality [8]

证券日报网讯12月1日，盈康生命（300143）在互动平台回答投资者提问时表示，截至2025年11月28 日，公司股东总数为20，122户。 ...

Market Overview - The medical services sector increased by 0.56% on November 25, with ST Zhongzhu leading the gains [1] - The Shanghai Composite Index closed at 3870.02, up 0.87%, while the Shenzhen Component Index closed at 12777.31, up 1.53% [1] Top Gainers in Medical Services - ST Zhongzhu (600568) closed at 2.57, up 4.90% with a trading volume of 53,900 shares and a turnover of 13.85 million yuan [1] - Chengda Pharmaceutical (301201) closed at 47.78, up 2.97% with a trading volume of 112,700 shares and a turnover of 540 million yuan [1] - Boji Pharmaceutical (300404) closed at 10.10, up 2.75% with a trading volume of 108,600 shares and a turnover of 10.9 million yuan [1] Top Losers in Medical Services - Jiuzhou Pharmaceutical (603456) closed at 18.75, down 0.85% with a trading volume of 181,100 shares and a turnover of 343 million yuan [2] - Tongce Medical (600763) closed at 41.95, down 0.66% with a trading volume of 49,600 shares and a turnover of 210 million yuan [2] - Yingkang Life (300143) closed at 10.12, down 0.49% with a trading volume of 44,700 shares and a turnover of 4.56 million yuan [2] Capital Flow Analysis - The medical services sector experienced a net outflow of 113 million yuan from institutional investors, while retail investors saw a net inflow of 30.37 million yuan [2][3] - Major stocks like WuXi AppTec (603259) had a net inflow of 67.13 million yuan from institutional investors, while Sunshine Nuohua (688621) saw a net outflow of 2.29 million yuan from retail investors [3] Summary of Individual Stock Performance - Sunshine Nuohua (688621) had a net inflow of 38.24 million yuan from institutional investors, but a net outflow of 3.59 million yuan from retail investors [3] - Chengda Pharmaceutical (301201) also saw a significant net inflow of 36.45 million yuan from institutional investors, with a net outflow of 13.58 million yuan from retail investors [3] - New Mileage (002219) had a net inflow of 14.15 million yuan from institutional investors, while retail investors experienced a net outflow of 6.70 million yuan [3]

11 月 21 日，以 " 智领健康未来 " 为主题的 2025 华夏大健康产业发展暨康复服务大会在北京召开。作为连续四届引领行业风向的标杆盛会，科技与创新 始终是贯穿全程的灵魂主线，而医疗健康企业在环境、社会及治理方面的表现同样被社会各界关注。 万得 ESG高级分析师 受邀发表了主题演讲，详细介绍了蒲公英指数的构建背景、评估体系及市场表现，强调该指数为医疗健康行业可持续发展提供了重 要参考。 万得首先介绍了 Wind 万得的业务背景： "Wind 是一家专业化的信息服务机构，为金融领域开发了信息检索、数据提取及组合管理等专业工具，是国内外 机构投资者的重要合作伙伴。 " 她特别指出， Wind 构建的独立 ESG 评级体系已广泛应用于政策研究、金融决策和企业实践当中，例如国务院发展研究 中心发布的报告及可持续挂钩债券发行实践。 蒲公英指数亦是 Wind ESG 评级体系的一次创新性应用。该指数由华夏时报大健康研究院与万得联合研发，从医疗健康领域 A 股 495 家公司中精选前 50 家组成 " 蒲公英 50 指数 " ，港股 262 家公司中精选 30 家组成 " 蒲公英 30 指数 " ，每月根据 ESG ...

Core Viewpoint - The 2025 Huaxia Health Industry Development and Rehabilitation Service Conference emphasizes the importance of technology and innovation in the healthcare sector, alongside the growing focus on environmental, social, and governance (ESG) performance of healthcare companies [2][3]. Group 1: ESG Rating System - The Dandelion Index, developed by Huaxia Times Health Research Institute and Wind, selects the top 50 companies from 495 A-share healthcare companies and 30 from 262 Hong Kong healthcare companies, adjusting the components monthly based on ESG scores [3][4]. - The ESG rating system evaluates companies on long-term management practices across environmental, social, and governance dimensions, incorporating over 500 indicators and 28 topics, with a focus on industry-specific issues [4][7]. Group 2: Index Performance - The Dandelion Index shows superior performance, with the Dandelion 50 Index rising approximately 29% year-to-date, outperforming the CSI 300 and healthcare industry indices by about 35 percentage points, with an annualized return of around 10% [8][11]. - The Dandelion 30 Index has achieved a year-to-date increase of 104%, significantly surpassing the Hong Kong healthcare industry index and the Hang Seng Index, with a five-year cumulative return of 63% [11][12]. Group 3: Company Ratings - 80 companies with excellent ESG performance are included in the Dandelion Index, with Haier Biomedical and Yinkang Life receiving the highest AAA rating [7]. - In the Dandelion 50 Index, 62% of companies are rated AA, while 34% are rated A; the Dandelion 30 Index has 77% rated AA, with no low-rated companies, contrasting with over 69% of the healthcare industry having low ratings [7][8]. Group 4: Call to Action - The conference encourages more companies to engage in ESG practices and register on the Wind ESG issuer communication platform for rating feedback, aiming to promote sustainable development in the industry [14].